Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Wildlife Health Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
The global wildlife health market is on an upward trajectory, driven by significant technological advancements and a heightened sense of urgency to mitigate the impact of zoonotic diseases. A new comprehensive research report available on our website delves deep into the dynamics shaping the industry's future, spotlighting the considerable growth anticipated for the sector between 2023 and 2027.
An in-depth analysis presented in the report sheds light on the rise in the demand for wildlife health services, with a notable emphasis on mammals, birds, fish, reptiles, and amphibians. The study offers insights into various aspects of the market, including the utilization of medicinal products, equipment, and consumables, along with their administration routes such as oral, injectable, and other methods. This research serves as a vital tool for stakeholders, showcasing the array of end-users ranging from zoos and wildlife sanctuaries to rescue and rehabilitation centers.
North America Leads the Charge in Wildlife Health Initiatives
As of the latest findings, North America emerged as the dominant region within the wildlife health space in 2022. The comprehensive report also furnishes detailed data on several other key regions, including Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa, along with country-specific analyses for markets such as Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, the USA, Canada, Italy, and Spain.
Technological Innovations Spearhead Market Evolution
Technological innovations are a principal force revolutionizing the wildlife health sector. Trailblazing companies within the market are embracing cutting-edge technologies to maintain their competitive edge, with notable examples like Merck Animal Health's introduction of WHISPER ON ARRIVAL technology. This innovation combines a specialized sound collection device with a predictive algorithm to enhance diagnostics and treatment efficacy for livestock illnesses such as Bovine Respiratory Disease (BRD).
Strategic movements within the industry are punctuated by significant acquisitions, as seen with Wedgewood Pharmacy's procurement of Wildlife Pharmaceuticals and ZooPharm, a signal of the growing need for specialized, compounded medications for a diverse range of animal species.
The Zoonotic Disease Threat Accelerates Market Demand
One of the critical drivers stimulating market expansion is the escalating incidence of zoonotic diseases, which form a bridge between animal illnesses and human infections. Evidence of the rising occurrence of these diseases underscores the necessity for the wildlife health market's services and products. The recent statistics from the European Food Safety Authority indicate a stark increase in zoonotic infections, illuminating the importance of this sector's role in global health.
Market Overview: Definition, Analysis, and Player Landscape
- The report frames the market's value in terms of enterprise revenue from the sale of goods and services relevant to wildlife health, with an emphasis on 'factory gate' values.
- Detailed assessments of the industry's key players offer a window into the competitive landscape, showcasing how enterprises like Bayer AG, Novartis AG, and Zoetis Inc., alongside many others, navigate the market.
- Revenue analyses are geographically specific, focusing on organizations within the market's operational realm, with exclusions noted for resales and revenues outside of the wildlife health sector.
As the wildlife health market continues to evolve in response to technological advancements, strategic industry plays, and rising health threats, the sector stands as a pivotal component of global ecological well-being. Stakeholders are encouraged to peruse the detailed report on our website for a comprehensive understanding of the current state and growth prospects of this dynamic market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $2.26 billion |
| Forecasted Market Value (USD) by 2027 | $3.35 billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- Bayer AG
- Novartis AG
- Merck & Co Inc.
- Boehringer Ingelheim International GmbH
- CSL Limited
- Zoetis Inc.
- Elanco Animal Health Incorporated
- IDEXX Laboratories Inc.
- Génia USA Inc.
- Ceva Santé Animale
- Orion Corporation
- Virbac Group
- Royal Canin
- Emergent BioSolutions Inc.
- Ceva Santé Animale Group
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC
- Dechra Pharmaceuticals
- Huvepharma
- Vétoquinol
- Vetoquinol S.A.
- Indian Immunologicals Limited
- Norbrook Laboratories Limited
- Heska Corporation
- Biogenesis Bago
- Animalcare Group plc
- Pneu-Dart Inc.
- PetAg Inc.
For more information about this report visit https://www.researchandmarkets.com/r/vkke5g
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
